UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

Scientific reports, 2019-02, Vol.9 (1), p.2150-2150, Article 2150

2019

Volltextzugriff (PDF)

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

Cancer letters, 2014-03, Vol.344 (2), p.157-165

2014

Volltextzugriff (PDF)

MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance

Current drug targets, 2014-01, Vol.15 (1), p.114-123

2014

Volltextzugriff (PDF)

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Oncotarget, 2015-06, Vol.6 (17), p.15425-15435

2015

Volltextzugriff (PDF)

Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testing

Clinical biochemistry, 2018-03, Vol.53, p.116-126

2018

Volltextzugriff (PDF)

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma

Cancer cell international, 2015-07, Vol.15 (1), p.76-76, Article 76

2015

Volltextzugriff (PDF)

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

NAR cancer, 2023-03, Vol.5 (1)

2023

Volltextzugriff (PDF)

Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA

Human genomics, 2022-12, Vol.16 (1), p.73-73, Article 73

2022

Volltextzugriff (PDF)

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (19), p.9646-9655

2006

Volltextzugriff (PDF)

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes

PloS one, 2013-01, Vol.8 (1), p.e52321-e52321

2013

Volltextzugriff (PDF)

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

PloS one, 2014-12, Vol.9 (12), p.e114696-e114696

2014

Volltextzugriff (PDF)

Identification of miRNAs contributing to neuroblastoma chemoresistance

Computational and structural biotechnology journal, 2015-01, Vol.13 (C), p.307-319

2015

Volltextzugriff (PDF)

Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds

Clinical cancer research, 2009-06, Vol.15 (11), p.3690-3696

2009

Volltextzugriff (PDF)

A recurrent and transesophageal echocardiography-associated outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae complex in cardiac surgery patients

Antimicrobial resistance & infection control, 2019-09, Vol.8 (1), p.152-152, Article 152

2019

Volltextzugriff (PDF)

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

PloS one, 2013-08, Vol.8 (8), p.e71776

2013

Volltextzugriff (PDF)

Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis

Experimental and molecular pathology, 2017-02, Vol.102 (1), p.25-31

2017

Volltextzugriff (PDF)

EVI1‐mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells

British journal of haematology, 2011-08, Vol.154 (3), p.337-348

2011

Volltextzugriff (PDF)

The role of serum erythropoietin levels in diagnosis and classification of erythrocytosis/polycythemia

Haematologica (Roma), 2005-11, Vol.90 Suppl, p.ELT04; author reply ELT05-ELT04; author reply ELT05

Van Maerken, Tom M A

2005

Volltextzugriff (PDF)

MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based Validation

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1654, p.197

2017

Volltextzugriff (PDF)

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy

Genome medicine, 2009-07, Vol.1 (7), p.74-74

2009

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)
Berichte
(1)

Sprache

Englisch
(56)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(37)
Humans
(32)
Oncology
(21)
Neuroblastoma
(15)
Mutation
(12)
Cell Line, Tumor
(11)
Neuroblastoma - Genetics
(11)
Female
(10)
Tumors
(8)
Adult
(7)
Animals
(7)
Cancer
(7)
Micrornas - Genetics
(7)
Neuroblastoma - Metabolism
(7)
Neuroblastoma - Pathology
(7)
Tumor Suppressor Protein P53 - Metabolism
(7)
Biological And Medical Sciences
(6)
Cell Cycle
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11

MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testing

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA

ALK positively regulates MYCN activity through repression of HBP1 expression

Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Identification of miRNAs contributing to neuroblastoma chemoresistance

Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds

A recurrent and transesophageal echocardiography-associated outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae complex in cardiac surgery patients

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis

EVI1‐mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells

The role of serum erythropoietin levels in diagnosis and classification of erythrocytosis/polycythemia

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based Validation

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy

Suchergebnisse filtern